1 / 4

Follow-on Biologics Market Outlook, Segment Analysis and Forecast to 2028

The global Follow-on Biologics Market is set to grow at a specified CAGR during the forecast period. Biologic medicines constitute significance in terms of patient illnesses. The medicines are grown out of living cells under laboratory conditions since these are hard to manufacture, complex and large. The production of biologics is also referred as production of reference products as it involves inheritance of complex biologics and exclusive details of manufacturing process.

abhjoshi94
Télécharger la présentation

Follow-on Biologics Market Outlook, Segment Analysis and Forecast to 2028

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Follow-on Biologics Market Outlook, Segment Analysis and Forecast to 2028 “Follow-on biologics market is driven by medical advances in treatment for serious illnesses followed by rise in patient care and surge in medicine manufacture.” The global Follow-on Biologics Market is set to grow at a specified CAGR during the forecast period. Biologic medicines constitute significance in terms of patient illnesses. The medicines are grown out of living cells under laboratory conditions since these are hard to manufacture, complex and large. The production of biologics is also referred as production of reference products as it involves inheritance of complex biologics and exclusive details of manufacturing process. Follow-on biologics market is driven by medical advances in treatment for serious illnesses followed by rise in patient care and surge in medicine manufacture. In addition, surging demands for low cost biological drugs is stimulating the market growth. Drug manufacturers are now producing generic biopharmaceuticals, however, pricing remains a big concern. Increase in costs of healthcare treatment, expensive form of drugs and rise in population is likely to stimulate the market growth. However, uncertainties on outcome effect by consumption of biologics and stringent regulations is more likely to disturb the market growth during the forecast period. Browse Full Research Report @ https://www.millioninsights.com/industry-reports/follow-on-biologics-market Follow-on biologics market is segmented by type comprising insulin, growth hormones, interferons, fertility hormones, fusion proteins and monoclonal antibodies. Application segment for the market comprises blood disorders, chronic and autoimmune diseases and oncology diseases. Geographical segmentation for the market spans North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America and Europe market is likely to grow at a higher rate due to rise in medical infrastructure and increase in activities pertaining to patient care. Increase in R&D activities for production of biosimilar & biologics drugs.

  2. The key players profiled in the follow-on biologics market report are Allergan, Allozyne, Alteogen, Alvogen, Amarey Novamedical, AstaZeneca, Bionovis, Biosidus, Bioton, CCM Duopharma, CCL Pharmaceuticals, Celltrion, Chong Kun Dang, Centocor Ortho Biotech, CinnaGen, Compass Biotechnologies, Ranbaxy, Syngene Pharmaceutical, Takeda, Zenotech, Zheijan Huahai Pharmaceutical. Get a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/follow-on-biologics-market/request-sample Market Segment: Leading players of Follow-on Biologics including: • Sandoz • Pfizer • Teva Pahrmaceutical • Celltrion • Biocon • Amgen • Samsung Biologics • Mylan • Dr. Reddy's Laboratories • Stada Arzneimittel AG Market split by Type, can be divided into: • Recombinant Non-glycosylated Proteins • Recombinant Glycosylated Proteins • Recombinant Peptides Market split by Application, can be divided into: • Oncology • Blood Disorders

  3. • Chronic Diseases • Autoimmune Diseases • Growth Hormone Deficiency • Infectious Diseases Market split by Sales Channel, can be divided into: • Direct Channel • Distribution Channel Market segment by Region/Country including: • North America (United States, Canada and Mexico) • Europe (Germany, UK, France, Italy, Russia and Spain etc.) • Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.) • South America Brazil, Argentina, Colombia and Chile etc.) • Middle East & Africa (South Africa, Egypt, Nigeria and Saudi Arabia etc.) See More Reports of This Category by Million Insights @ https://www.millioninsights.com/industry/biotechnology

  4. Get in touch At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions. Contact Person: Ryan Manuel Research Support Specialist, USA Email: ryan@millioninsights.com Global Headquarters Asia Pacific Million Insights Million Insights Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India Phone: 1-408-610-2300 Email: sales@millioninsights.com Phone: 91-20-65300184 Email: sales@millioninsights.com Visit Our Blog: www.millioninsights.blogspot.com

More Related